Agency Forms Undergoing Paperwork Reduction Act Review, 46828-46829 [2014-18844]

Download as PDF 46828 Federal Register / Vol. 79, No. 154 / Monday, August 11, 2014 / Notices calculates and publishes weekly statistics via the Morbidity and Mortality Weekly Report (MMWR), providing the states with timely aggregates of their submissions. The following diseases/conditions are included in this program: Influenza Virus, Caliciviruses, Respiratory and Enteric Viruses, Foodborne Outbreaks, Waterborne Outbreaks, and Enteroviruses. These data are essential on the local, state, and Federal levels for measuring trends in diseases, evaluating the effectiveness of current prevention strategies, and determining the need for modifying current prevention measures. This request is for revision of the currently approved data collection for three years. The revisions include shifting information collection management responsibilities from the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) to the National Center for Immunization and Respiratory Diseases (NCIRD) and consolidating various forms to reflect more current technology trends. In addition, to gauge the potential threat to human health, a new Middle East Respiratory Syndrome Coronavirus (MERS-CoV) patient investigation data collection form has been added. A new Adenovirus Typing Report form is also included and will allow for a passive surveillance mechanism which will enhance the adenovirus circulation data that’s already collected by the National Respiratory and Enteric Virus Surveillance System (NREVSS). Furthermore, minor changes have been made to the forms related to Human Infection with Novel Influenza A Virus. The Harmful Algal Bloom-related Illness forms are being discontinued. The methodology for reporting varies depending on the occurrence, modes of transmission, infectious agents, and epidemiologic measures. There is no cost to respondents other than their time. The total estimated annual burden hours are 31,836. the items contained in this notice should be directed to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–14–0004] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Written comments and/or suggestions regarding Proposed Project National Disease Surveillance Program—II. Disease Summaries (OMB No. 0920–0004, Expires 8/31/2014)— Revision—National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Background and Brief Description Surveillance of the incidence and distribution of disease has been an important function of the U.S. Public Health Service (PHS) since 1878. Through the years, PHS/CDC has formulated practical methods of disease control through field investigations. The CDC National Disease Surveillance Program is based on the premise that diseases cannot be diagnosed, prevented, or controlled until existing knowledge is expanded and new ideas developed and implemented. Over the years, the mandate of CDC has broadened to include preventive health activities and the surveillance systems maintained have expanded. Data on disease and preventable conditions are collected in accordance with jointly approved plans by CDC and the Council of State and Territorial Epidemiologists (CSTE). Changes in the surveillance program and in reporting methods are effected in the same manner. At the beginning of this surveillance program in 1968, CSTE and CDC decided which diseases warranted surveillance. These diseases are reviewed and revised based on variations in the public’s health. Surveillance forms are distributed to State and local health department staff, who voluntarily submit these reports to CDC on variable frequencies—weekly, monthly, or quarterly. CDC then ESTIMATE OF ANNUALIZED BURDEN HOURS Number of respondents mstockstill on DSK4VPTVN1PROD with NOTICES Type of respondents—state epidemiologists Form Name Foodborne Disease Transmission_Person to Person_Animal Contact CDC 52.13 ................... WHO Collaborating Center for Influenza: Influenza Virus Surveillance (Internet; year round) (CDC 55.31) ............................................................................................................................. U.S. WHO Collaborating Laboratories Influenza Testing Methods Assessment ........................ US Outpatient Influenza-like Illness Surveillance Network (ILINet) Weekly (CDC 55.20) .......... US Outpatient Influenza-like Illness Surveillance Network (ILINet) Daily ILINet, Reports of Influenza-Like Illness (ILI) ........................................................................................................... Influenza-Associated Pediatric Mortality Case Report Form ...................................................... VerDate Mar<15>2010 17:35 Aug 08, 2014 Jkt 232001 PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 E:\FR\FM\11AUN1.SGM Number of responses per respondent Average burden per response (in hours) 54 32 20/60 35 87 1,800 52 1 52 10/60 10/60 10/60 75 57 365 2 10/60 30/60 11AUN1 46829 Federal Register / Vol. 79, No. 154 / Monday, August 11, 2014 / Notices ESTIMATE OF ANNUALIZED BURDEN HOURS—Continued Number of respondents Type of respondents—state epidemiologists Human Infection with Novel Influenza A Virus Case Report Form ............................................. Human Infection with Novel Influenza A Virus with Suspected Avian Source ........................... Human Infection with Novel Influenza A Virus Severe Outcomes .............................................. Novel Influenza A Virus Infection Contact Tracing Form ............................................................ Novel Influenza A Virus Case Status Summary ......................................................................... Novel Influenza A Virus Case Screening Form .......................................................................... 122 CMRS—City health officers or vital statistics registrars Daily Mortality Report ................... 122 CMRS—City health officers or vital statistics registrars Weekly Mortality Report ............... Aggregate Hospitalization and Death Reporting Activity Weekly Report Form .......................... Antiviral Resistant Influenza Infection Case Report Form .......................................................... National Respiratory & Enteric Virus Surveillance System (NREVSS) (CDC 55.83 Lab Assessment Form, 55.83A, B, D) (electronic) ............................................................................. National Enterovirus Surveillance Report: (CDC 55.9) (electronic) ............................................ Adenovirus Typing Report Form ................................................................................................. Middle East Respiratory Syndrome Coronavirus (MERS) Patient Under Investigation (PUI) Form ......................................................................................................................................... Form for Submitting Specimens From Suspected Norovirus Outbreaks .................................... Waterborne Disease Transmission CDC 52.12 .......................................................................... Influenza Virus (Electronic, Year Round), PHLIP_HL7 messaging Data Elements ................... -Influenza virus (electronic, year round) (PHIN–MS) .................................................................. Leroy Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2014–18844 Filed 8–8–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–14–0910] mstockstill on DSK4VPTVN1PROD with NOTICES Proposed Data Collections Submitted for Public Comment and Recommendations The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. To request more information on the below proposed project or to obtain a copy of the information collection plan and instruments, call 404–639–7570 or send comments to Leroy Richardson, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an email to omb@cdc.gov. Comments submitted in response to this notice will be summarized and/or included in the request for Office of Management and Budget (OMB) approval. Comments are invited on: (a) VerDate Mar<15>2010 17:35 Aug 08, 2014 Jkt 232001 Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) estimates of capital or start-up costs and costs of operation, maintenance, and purchase of services to provide information. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information, to search data sources, to complete and review the collection of information; and to transmit or otherwise disclose the information. Written comments should be received within 60 days of this notice. Proposed Project Message Testing for Tobacco Communication Activities (OMB No. PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 Number of responses per respondent Average burden per response (in hours) 57 57 57 57 57 57 58 122 56 57 6 1 1 1 1 1 365 52 52 3 30/60 30/60 1.5/60 30/60 15/60 15/60 12/60 12/60 10/60 30/60 300 25 25 52 12 12 15/60 15/60 15/60 57 20 57 49 3 3 5 1 52 52 25/60 15/60 20/60 5/60 5/60 0920–0910, exp. 1/31/2015)— Revision—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description In 2012, CDC’s Office on Smoking and Health obtained OMB approval of a generic clearance that established a unified information collection framework for the development of tobacco-related health messages, including messages related to CDC’s ACA-funded tobacco education campaign (Message Testing for Tobacco Communication Activities (MTTCA), OMB No. 0920–0910, exp. 1/31/2015). The MTTCA clearance was initially approved with the following estimates: 14,974 annualized responses and 5,775 annualized burden hours. On January 2, 2014, CDC obtained OMB approval to increase the capacity of the MTTCA clearance to 36,847 annualized responses and 7,219 burden hours. CDC has employed the MTTCA clearance to collect information about adult smokers’ and nonsmokers’ attitudes and perceptions, and to pretest draft messages and materials for clarity, salience, appeal, and persuasiveness. A variety of information collection strategies are supported through this mechanism, including indepth interviews, in-person focus groups, online focus groups, computerassisted, in-person, or telephone interviews, and online surveys. CDC requests OMB approval for each data collection by submitting a project- E:\FR\FM\11AUN1.SGM 11AUN1

Agencies

[Federal Register Volume 79, Number 154 (Monday, August 11, 2014)]
[Notices]
[Pages 46828-46829]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-18844]

[[Page 46828]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-14-0004]

Agency Forms Undergoing Paperwork Reduction Act Review

The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.

Proposed Project

National Disease Surveillance Program--II. Disease Summaries (OMB
No. 0920-0004, Expires 8/31/2014)--Revision--National Center for
Immunization and Respiratory Diseases, Centers for Disease Control and
Prevention (CDC).

Background and Brief Description

Surveillance of the incidence and distribution of disease has been
an important function of the U.S. Public Health Service (PHS) since
1878. Through the years, PHS/CDC has formulated practical methods of
disease control through field investigations. The CDC National Disease
Surveillance Program is based on the premise that diseases cannot be
diagnosed, prevented, or controlled until existing knowledge is
expanded and new ideas developed and implemented. Over the years, the
mandate of CDC has broadened to include preventive health activities
and the surveillance systems maintained have expanded.
Data on disease and preventable conditions are collected in
accordance with jointly approved plans by CDC and the Council of State
and Territorial Epidemiologists (CSTE). Changes in the surveillance
program and in reporting methods are effected in the same manner. At
the beginning of this surveillance program in 1968, CSTE and CDC
decided which diseases warranted surveillance. These diseases are
reviewed and revised based on variations in the public's health.
Surveillance forms are distributed to State and local health department
staff, who voluntarily submit these reports to CDC on variable
frequencies--weekly, monthly, or quarterly. CDC then calculates and
publishes weekly statistics via the Morbidity and Mortality Weekly
Report (MMWR), providing the states with timely aggregates of their
submissions.
The following diseases/conditions are included in this program:
Influenza Virus, Caliciviruses, Respiratory and Enteric Viruses,
Foodborne Outbreaks, Waterborne Outbreaks, and Enteroviruses. These
data are essential on the local, state, and Federal levels for
measuring trends in diseases, evaluating the effectiveness of current
prevention strategies, and determining the need for modifying current
prevention measures.
This request is for revision of the currently approved data
collection for three years. The revisions include shifting information
collection management responsibilities from the National Center for
Emerging and Zoonotic Infectious Diseases (NCEZID) to the National
Center for Immunization and Respiratory Diseases (NCIRD) and
consolidating various forms to reflect more current technology trends.
In addition, to gauge the potential threat to human health, a new
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) patient
investigation data collection form has been added. A new Adenovirus
Typing Report form is also included and will allow for a passive
surveillance mechanism which will enhance the adenovirus circulation
data that's already collected by the National Respiratory and Enteric
Virus Surveillance System (NREVSS). Furthermore, minor changes have
been made to the forms related to Human Infection with Novel Influenza
A Virus. The Harmful Algal Bloom-related Illness forms are being
discontinued.
The methodology for reporting varies depending on the occurrence,
modes of transmission, infectious agents, and epidemiologic measures.
There is no cost to respondents other than their time.
The total estimated annual burden hours are 31,836.

Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents--state epidemiologists respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Form Name

Foodborne Disease Transmission--Person to Person--Animal Contact 54 32 20/60
CDC 52.13......................................................
WHO Collaborating Center for Influenza: Influenza Virus 35 52 10/60
Surveillance (Internet; year round) (CDC 55.31)................
U.S. WHO Collaborating Laboratories Influenza Testing Methods 87 1 10/60
Assessment.....................................................
US Outpatient Influenza-like Illness Surveillance Network 1,800 52 10/60
(ILINet) Weekly (CDC 55.20)....................................
US Outpatient Influenza-like Illness Surveillance Network 75 365 10/60
(ILINet) Daily ILINet, Reports of Influenza-Like Illness (ILI).
Influenza-Associated Pediatric Mortality Case Report Form....... 57 2 30/60

[[Page 46829]]

Human Infection with Novel Influenza A Virus Case Report Form... 57 6 30/60
Human Infection with Novel Influenza A Virus with Suspected 57 1 30/60
Avian Source...................................................
Human Infection with Novel Influenza A Virus Severe Outcomes.... 57 1 1.5/60
Novel Influenza A Virus Infection Contact Tracing Form.......... 57 1 30/60
Novel Influenza A Virus Case Status Summary..................... 57 1 15/60
Novel Influenza A Virus Case Screening Form..................... 57 1 15/60
122 CMRS--City health officers or vital statistics registrars 58 365 12/60
Daily Mortality Report.........................................
122 CMRS--City health officers or vital statistics registrars 122 52 12/60
Weekly Mortality Report........................................
Aggregate Hospitalization and Death Reporting Activity Weekly 56 52 10/60
Report Form....................................................
Antiviral Resistant Influenza Infection Case Report Form........ 57 3 30/60
National Respiratory & Enteric Virus Surveillance System 300 52 15/60
(NREVSS) (CDC 55.83 Lab Assessment Form, 55.83A, B, D)
(electronic)...................................................
National Enterovirus Surveillance Report: (CDC 55.9) 25 12 15/60
(electronic)...................................................
Adenovirus Typing Report Form................................... 25 12 15/60
Middle East Respiratory Syndrome Coronavirus (MERS) Patient 57 3 25/60
Under Investigation (PUI) Form.................................
Form for Submitting Specimens From Suspected Norovirus Outbreaks 20 5 15/60
Waterborne Disease Transmission CDC 52.12....................... 57 1 20/60
Influenza Virus (Electronic, Year Round), PHLIP--HL7 messaging 49 52 5/60
Data Elements..................................................
-Influenza virus (electronic, year round) (PHIN-MS)............. 3 52 5/60
----------------------------------------------------------------------------------------------------------------

Leroy Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-18844 Filed 8-8-14; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.